Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03124056
What this trial is testing

Clinical and Biomarker Study of the Efficacy of Extracorporeal Photopheresis in Graft-versus-host Disease

Who this might be right for
Graft-versus-host Disease
Fundación para la Investigación del Hospital Clínico de Valencia 62
Testing effectiveness (Phase 2)Looking for participantsNCT05922761
What this trial is testing

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

Who this might be right for
Bronchiolitis Obliterans SyndromeBronchiolitis ObliteransLung Diseases+1 more
Dana-Farber Cancer Institute 45
Testing effectiveness (Phase 2)Study completedNCT00003894
What this trial is testing

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 36
Testing effectiveness (Phase 2)WithdrawnNCT05604742
What this trial is testing

Belimumab for Treatment of cGVHD Following Allo-HCT

Who this might be right for
cGVHD
xuna
Testing effectiveness (Phase 2)Study completedNCT00003838
What this trial is testing

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Who this might be right for
Myeloproliferative DisordersAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 202
Early research (Phase 1)Ended earlyNCT00725062
What this trial is testing

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05364762
What this trial is testing

Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+4 more
City of Hope Medical Center 20
Not applicableActive Not RecruitingNCT00637689
What this trial is testing

Improving Outcomes Assessment in Chronic GVHD

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 601
Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03779854
What this trial is testing

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+14 more
Fred Hutchinson Cancer Center 45
Large-scale testing (Phase 3)UnknownNCT01526850
What this trial is testing

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Chinese Academy of Medical Sciences 100
Testing effectiveness (Phase 2)Study completedNCT00054340
What this trial is testing

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02345850
What this trial is testing

Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

Who this might be right for
Acute LeukemiaMyelodysplasia
National Heart, Lung, and Blood Institute (NHLBI) 346
Early research (Phase 1)Study completedNCT00529035
What this trial is testing

Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 29
Early research (Phase 1)Study completedNCT06638879
What this trial is testing

Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)

Who this might be right for
Chronic Graft Versus Host Disease Oral
Children's Hospital Medical Center, Cincinnati 7
Testing effectiveness (Phase 2)Study completedNCT00048789
What this trial is testing

Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease

Who this might be right for
Graft vs Host Disease
National Institute of Allergy and Infectious Diseases (NIAID) 25
Not applicableNo Longer AvailableNCT02258490
What this trial is testing

Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation

Who this might be right for
Chronic Myeloid LeukemiaMyelodysplastic SyndromeAcute Myeloid Leukemia
Emory University
Testing effectiveness (Phase 2)Study completedNCT00074035
What this trial is testing

Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host Disease
Alliance for Clinical Trials in Oncology 39
Early research (Phase 1)Ended earlyNCT02086513
What this trial is testing

Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT

Who this might be right for
Graft Versus Host Disease
Massachusetts General Hospital 17
Testing effectiveness (Phase 2)UnknownNCT00472225
What this trial is testing

Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease

Who this might be right for
Steroid-Refractory Chronic GVHD
The Korean Society of Hematopoietic Stem Cell Transplantation 42
Next Page